e-learning
resources
Paris 2018
Monday, 17.09.2018
COPD, asthma and tuberculosis: benefits related to therapy costs
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cost-utility analysis of a Home-based disease management intervention for patients with severe COPD in the COMET study.
D. GRANADOS (Gentilly, France), J. Bourbeau (Montreal, Canada), I. Durand-Zaleski (Paris, France), S. Roze (Lyon, France), R. Kessler (Strasbourg, France)
Source:
International Congress 2018 – COPD, asthma and tuberculosis: benefits related to therapy costs
Session:
COPD, asthma and tuberculosis: benefits related to therapy costs
Session type:
Thematic Poster
Number:
3162
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. GRANADOS (Gentilly, France), J. Bourbeau (Montreal, Canada), I. Durand-Zaleski (Paris, France), S. Roze (Lyon, France), R. Kessler (Strasbourg, France). Cost-utility analysis of a Home-based disease management intervention for patients with severe COPD in the COMET study.. 3162
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Cost-effectiveness analysis of a Home-based disease management intervention for patients with severe COPD alongside the COMET study.
Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet?
Year: 2018
Effectiveness of a comprehensive management program of fragile COPD patients
Source: International Congress 2016 – In-patient and out-patient COPD management
Year: 2016
Effectiveness of a home-based pulmonary rehabilitation program compared to a hospital-based pulmonary rehabiltation program in COPD patients. A Spanish multicenter randomized trial
Source: Annual Congress 2006 - Organisation and programmes in pulmonary rehabilitation
Year: 2006
Cost-effectiveness of an INTERdisciplinary COMmunity-based COPD lifestyle program (INTERCOM) in patients with moderate COPD
Source: Annual Congress 2008 - Strategies of patient management in different settings
Year: 2008
COMET: a multicomponent home-based disease-management programme
versus
routine care in severe COPD
Source: Eur Respir J, 51 (1) 1701612; 10.1183/13993003.01612-2017
Year: 2018
Is treatment with ICS and LABA cost-effective for COPD? Multinational economic analysis of the TORCH study
Source: Eur Respir J 2010; 35: 532-539
Year: 2010
Characteristics of effective self-management interventions in patients with COPD: individual patient data meta-analysis
Source: Eur Respir J 2016; 48: 55-68
Year: 2016
LATE-BREAKING ABSTRACT: A cluster randomised controlled trial evaluating the effectiveness of a structured pulmonary rehabilitation education programme in a primary care setting for people with chronic obstructive pulmonary disease (COPD): The PRINCE Study.
Source: Annual Congress 2013 –Management of respiratory diseases in primary care
Year: 2013
Pilot study of effectiveness of home rehabilitation for homebound patients with severe COPD
Source: Annual Congress 2011 - Pulmonary rehabilitation: looking at alternative approaches and alternative populations beyond COPD
Year: 2011
Top-10 comorbidities of symptomatic patients with moderate COPD in the clinical setting of the CRYSTAL study
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016
A randomised controlled clinical trial of supervised exercise with the chronic disease self-management programme (CDSMP) for people with COPD
Source: Annual Congress 2009 - Emerging treatment and assessment strategies in pulmonary rehabilitation
Year: 2009
Effects of a comprehensive self-management programme in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: 815-820
Year: 2003
Costs and effects of structured COPD care – An observational, matched-cohort study
Source: Annual Congress 2013 –Early diagnosis and effectiveness of disease management in primary care
Year: 2013
Assessment of a disease management program for patients with asthma or COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 19s
Year: 2005
Cost-benefit and cost-effectiveness analysis of self-management in patients with COPD - a one-year follow-up randomised, controlled trial
Source: Eur Respir J 2002; 20: Suppl. 38, 67s
Year: 2002
Efficacy of comprehensive education program including inhaler training and disease management on COPD
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016
Efficacy of home-based pulmonary rehabilitation program for the patients with chronic lung diseases
Source: Eur Respir J 2003; 22: Suppl. 45, 164s
Year: 2003
Long-term effect of comprehensive home-based pulmonary rehabilitation in patients with COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 223s
Year: 2001
Clinical characteristics and outcomes of elderly patients with COPD: TIOSPIR® post-hoc analysis
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept